MetLife Investment Management, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$214,938
-31.2%
242,594
+22.0%
0.00%
-33.3%
Q3 2022$312,242
-21.9%
198,8800.0%0.00%0.0%
Q2 2022$399,749
+45.5%
198,880
+68.6%
0.00%
+50.0%
Q1 2022$274,826
-43.5%
117,951
+12.8%
0.00%
-50.0%
Q4 2021$486,088
-27.7%
104,535
+18.6%
0.00%
-33.3%
Q3 2021$672,760
-29.4%
88,173
-10.3%
0.01%
-33.3%
Q2 2021$952,876
+38.7%
98,336
+18.4%
0.01%
+28.6%
Q1 2021$687,146
-1.6%
83,089
-18.8%
0.01%0.0%
Q4 2020$698,668
-33.3%
102,369
+9.0%
0.01%
-36.4%
Q3 2020$1,047,520
+110.4%
93,948
+18.5%
0.01%
+83.3%
Q2 2020$497,834
+327.2%
79,273
+25.2%
0.01%
+200.0%
Q1 2020$116,524
-9.0%
63,328
+67.2%
0.00%
+100.0%
Q4 2019$128,034
-7.4%
37,880
-41.4%
0.00%
-50.0%
Q3 2019$138,293
-11.9%
64,623
+9.9%
0.00%0.0%
Q2 2019$157,004
-22.7%
58,803
+37.5%
0.00%0.0%
Q1 2019$203,200
+97.9%
42,7790.0%0.00%
+100.0%
Q4 2018$102,670
-45.5%
42,7790.0%0.00%
-50.0%
Q3 2018$188,228
-38.9%
42,7790.0%0.00%
-50.0%
Q2 2018$308,00042,7790.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders